Exploring the Common Gene Signatures Between Myocardial Infarction-Reperfusion Injury and the Gut Microbiome Using Bioinformatics
DOI:
https://doi.org/10.59958/hsf.5775Keywords:
myocardium ischemia-reperfusion injury, gut microbiome disorder, bioinformatics, cross-talk genes, B2m, PDIA4Abstract
Background: This bioinformatics report attempts to explore the cross-talk genes, transcription factors (TFs), and pathways related to myocardial ischemia-reperfusion injury (MIRI) as well as the gut microbiome. Method: The datasets GSE61592 (three MIRI and three sham samples) and GSE160516 (twelve MIRI and four sham samples) were selected in the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) identification (p < 0.05 and |log FC (fold change)| ≥1) together with functional annotation (p < 0.05) was implemented. The Cytoscape platform established the protein-protein interaction (PPI) network. Genes associated with gut microbiome disorder were extracted based on the DisGeNET database, and those associated with MIRI were overlapped. The Recursive Feature Elimination (RFE) algorithm was adopted for selecting features, and cross-talk genes were predicted by the Support Vector Machine (SVM) models. A network encompassing cross-talk genes along with the TFs was thereby established. Result: The MIRI datasets comprised 138 shared DEGs, with 101 showing up-regulation whereas 37 showing down-regulation. Notably, the PPI interwork for MIRI contained 2517 edges along with 1818 nodes. By using RFE and SVM methods, six feature genes with the highest prediction were identified: B2m, VCAM-1, PDIA4, Ptgds, Mlxipl, and ACADS. Among these genes, B2m and PDIA4 were most highly expressed in MIRI and the gut microbiome disorder. Conclusion: B2m and PDIA4 were identified to be significantly correlated with candidate cross-talk genes of MIRI with gut microbiome disorder, implying a similarity between MIRI and Gut microbiome disorder (GMD). These genes can serve as an experimental research basis for future studies.
References
Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nature Reviews. Cardiology. 2020; 17: 773–789.
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. The Journal of Clinical Investigation. 2013; 123: 92–100.
Heusch G, Rassaf T. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning. Circulation Research. 2016; 119: 676–695.
Zhou H, Zhu P, Guo J, Hu N, Wang S, Li D, et al. Ripk3 induces mitochondrial apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury. Redox Biology. 2017; 13: 498–507.
Wu MY, Yiang GT, Liao WT, Tsai APY, Cheng YL, Cheng PW, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 2018; 46: 1650–1667.
Sánchez-Hernández CD, Torres-Alarcón LA, González-Cortés A, Peón AN. Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches. Mediators of Inflammation. 2020; 2020: 8405370.
Ghafouri-Fard S, Shoorei H, Taheri M. Non-coding RNAs participate in the ischemia-reperfusion injury. Biomedicine & Pharmacotherapy. 2020; 129: 110419.
Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications. 2012; 3: 1245.
Vinjé S, Stroes E, Nieuwdorp M, Hazen SL. The gut microbiome as novel cardio-metabolic target: the time has come!. European Heart Journal. 2014; 35: 883–887.
Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes, Obesity & Metabolism. 2012; 14: 112–120.
Sirisinha S. The potential impact of gut microbiota on your health: Current status and future challenges. Asian Pacific Journal of Allergy and Immunology. 2016; 34: 249–264.
Kaptoge S, Seshasai SRK, Gao P, Freitag DF, Butterworth AS, Borglykke A, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. European Heart Journal. 2014; 35: 578–589.
Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Current Opinion in Gastroenterology. 2015; 31: 69–75.
Cerdó T, Ruiz A, Acuña I, Jáuregui R, Jehmlich N, Haange SB, et al. Gut microbial functional maturation and succession during human early life. Environmental Microbiology. 2018; 20: 2160–2177.
Zhen Y, Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Frontiers in Immunology. 2019; 10: 276.
Ladinsky MS, Araujo LP, Zhang X, Veltri J, Galan-Diez M, Soualhi S, et al. Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis. Science (New York, N.Y.). 2019; 363: eaat4042.
Yang M, Zhang Y, Ren J. Autophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome. Frontiers in Cardiovascular Medicine. 2018; 5: 38.
Yang Q, Lin SL, Kwok MK, Leung GM, Schooling CM. The Roles of 27 Genera of Human Gut Microbiota in Ischemic Heart Disease, Type 2 Diabetes Mellitus, and Their Risk Factors: A Mendelian Randomization Study. American Journal of Epidemiology. 2018; 187: 1916–1922.
Li S, Zhou C, Xu Y, Wang Y, Li L, Pelekos G, et al. Similarity and Potential Relation Between Periimplantitis and Rheumatoid Arthritis on Transcriptomic Level: Results of a Bioinformatics Study. Frontiers in Immunology. 2021; 12: 702661.
Zeng Y, Cao S, Chen M. Integrated analysis and exploration of potential shared gene signatures between carotid atherosclerosis and periodontitis. BMC Medical Genomics. 2022; 15: 227.
Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology. 2019; 37: 773–782.
Tan L, Tejada T, Torres R, Calvert J, Pejler G, Abrink M, et al. Abstract P229: Chymase-mediated Igf-1 Degradation Promotes Delayed Cell Death in Post-ischemic Hearts. Hypertension. 2016; 68: AP229–AP229.
Zhao W, Wang L, Haller V, Ritsch A. A Novel Candidate for Prevention and Treatment of Atherosclerosis: Urolithin B Decreases Lipid Plaque Deposition in apoE-/- Mice and Increases Early Stages of Reverse Cholesterol Transport in ox-LDL Treated Macrophages Cells. Molecular Nutrition & Food Research. 2019; 63: e1800887.
Kurilshikov A, van den Munckhof ICL, Chen L, Bonder MJ, Schraa K, Rutten JHW, et al. Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk. Circulation Research. 2019; 124: 1808–1820.
Wang NC, Chen HW, Lin TY. Association of protein disulfide isomerase family A, member 4, and inflammation in people living with HIV. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases. 2023; 126: 79–86.
Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. BMC Cell Biology. 2009; 10: 61.
Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Molecular & Cellular Proteomics: MCP. 2008; 7: 1434–1451.
Di Jeso B, Morishita Y, Treglia AS, Lofrumento DD, Nicolardi G, Beguinot F, et al. Transient covalent interactions of newly synthesized thyroglobulin with oxidoreductases of the endoplasmic reticulum. The Journal of Biological Chemistry. 2014; 289: 11488–11496.
Menon S, Lee J, Abplanalp WA, Yoo SE, Agui T, Furudate SI, et al. Oxidoreductase interactions include a role for ERp72 engagement with mutant thyroglobulin from the rdw/rdw rat dwarf. The Journal of Biological Chemistry. 2007; 282: 6183–6191.
De Santis S, Cavalcanti E, Mastronardi M, Jirillo E, Chieppa M. Nutritional Keys for Intestinal Barrier Modulation. Frontiers in Immunology. 2015; 6: 612.
Yang D, Han Z, Oppenheim JJ. Alarmins and immunity. Immunological Reviews. 2017; 280: 41–56.
Deguine J, Barton GM. MyD88: a central player in innate immune signaling. F1000prime Reports. 2014; 6: 97.
Sedighi O, Abediankenari S, Omranifar B. Association between plasma Beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease. Nephro-urology Monthly. 2014; 7: e23563.
Cheung CL, Lam KSL, Cheung BMY. Serum β-2 microglobulin predicts mortality in people with diabetes. European Journal of Endocrinology. 2013; 169: 1–7.
Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2002; 17: 28–31.
Kals J, Zagura M, Serg M, Kampus P, Zilmer K, Unt E, et al. β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients. Scandinavian Journal of Clinical and Laboratory Investigation. 2011; 71: 257–263.
Wu HC, Lee LC, Wang WJ. Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease. Journal of Clinical Laboratory Analysis. 2017; 31: e22056.
Molenaar B, Timmer LT, Droog M, Perini I, Versteeg D, Kooijman L, et al. Single-cell transcriptomics following ischemic injury identifies a role for B2M in cardiac repair. Communications Biology. 2021; 4: 146.
Psarras S, Beis D, Nikouli S, Tsikitis M, Capetanaki Y. Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes. Frontiers in Cardiovascular Medicine. 2019; 6: 32.
Shao L, Zhang Y, Pan X, Liu B, Liang C, Zhang Y, et al. Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection. Cellular and Molecular Life Sciences: CMLS. 2020; 77: 937–952.
Krzystek-Korpacka M, Diakowska D, Bania J, Gamian A. Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer: implications for finding suitable normalizers for inflammatory bowel disease studies. Inflammatory Bowel Diseases. 2014; 20: 1147–1156.
Weidner J, Jarenbäck L, Åberg I, Westergren-Thorsson G, Ankerst J, Bjermer L, et al. Endoplasmic reticulum, Golgi, and lysosomes are disorganized in lung fibroblasts from chronic obstructive pulmonary disease patients. Physiological Reports. 2018; 6: e13584.
Tufo G, Jones AWE, Wang Z, Hamelin J, Tajeddine N, Esposti DD, et al. The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma. Cell Death and Differentiation. 2014; 21: 685–695.
Jiao G, Hao L, Wang M, Zhong B, Yu M, Zhao S, et al. Upregulation of endoplasmic reticulum stress is associated with diaphragm contractile dysfunction in a rat model of sepsis. Molecular Medicine Reports. 2017; 15: 366–374.
Winship AL, Sorby K, Correia J, Rainczuk A, Yap J, Dimitriadis E. Interleukin-11 up-regulates endoplasmic reticulum stress induced target, PDIA4 in human first trimester placenta and in vivo in mice. Placenta. 2017; 53: 92–100.
Zhang Y, Zhou H, Wu W, Shi C, Hu S, Yin T, et al. Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radical Biology & Medicine. 2016; 95: 278–292.
Zhu P, Hu S, Jin Q, Li D, Tian F, Toan S, et al. Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway. Redox Biology. 2018; 16: 157–168.
Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nature Cell Biology. 2000; 2: 326–332.
Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. Journal of Biological Chemistry. 2004; 279: 25935–25938.
Zhang K, Kaufman RJ. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology. 2006; 66: S102–S109.
Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008; 454: 455–462.
Stopa JD, Zwicker JI. The intersection of protein disulfide isomerase and cancer associated thrombosis. Thrombosis Research. 2018; 164: S130–S135.
Essex DW, Wu Y. Multiple protein disulfide isomerases support thrombosis. Current Opinion in Hematology. 2018; 25: 395–402.
Zhou J, Wu Y, Chen F, Wang L, Rauova L, Hayes VM, et al. The disulfide isomerase ERp72 supports arterial thrombosis in mice. Blood. 2017; 130: 817–828.
